Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S Quante

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer Medicine|July 1, 2016
Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030Anne S Quante, Chang Ming, Miriam Rottmann, et al.
Frontiers in Pharmacology|June 16, 2025
Translational studies on pancreatic cancer and gastric cancer: a methodology in PhD thesisMathilde Resell, Gunnar Qvigstad, Timothy C Wang, et al.
Oncology Research and Treatment|February 28, 2018
The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 StudyCatherine P Cheney, Barbara Thorand, Cornelia Huth, et al.
Acta Diabetologica|August 5, 2020
Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from GermanyGregory G Greiner, Karl M F Emmert-Fees, Jana Becker, et al.
Archives of Gynecology and Obstetrics|November 27, 2020
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challengeSabine Grill, Juliane Ramser, Heide Hellebrand, et al.
Biomarkers in Medicine|November 29, 2022
NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancerSarah M Konrad, Kristina Schwamborn, Achim Krüger, et al.
European Journal of Nutrition|May 16, 2019
Modifying effect of metabotype on diet-diabetes associationsAnna Riedl, Nina Wawro, Christian Gieger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 19, 2020
Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in GermanyMelissa Schmidt, Donna P Ankerst, Yiyao Chen, et al.
Breast Cancer Research and Treatment|September 27, 2021
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1Leonie Neirich, Maryam Yahiaoui-Doktor, Jacqueline Lammert, et al.
Journal of Medical Genetics|October 24, 2006
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutationsMartin Zenker, Katarina Lehmann, Anna Leana Schulz, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Medicine|July 1, 2016
Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030Anne S Quante, Chang Ming, Miriam Rottmann, et al.
Frontiers in Pharmacology|June 16, 2025
Translational studies on pancreatic cancer and gastric cancer: a methodology in PhD thesisMathilde Resell, Gunnar Qvigstad, Timothy C Wang, et al.
Oncology Research and Treatment|February 28, 2018
The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 StudyCatherine P Cheney, Barbara Thorand, Cornelia Huth, et al.
Acta Diabetologica|August 5, 2020
Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from GermanyGregory G Greiner, Karl M F Emmert-Fees, Jana Becker, et al.
Archives of Gynecology and Obstetrics|November 27, 2020
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challengeSabine Grill, Juliane Ramser, Heide Hellebrand, et al.
Biomarkers in Medicine|November 29, 2022
NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancerSarah M Konrad, Kristina Schwamborn, Achim Krüger, et al.
European Journal of Nutrition|May 16, 2019
Modifying effect of metabotype on diet-diabetes associationsAnna Riedl, Nina Wawro, Christian Gieger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 19, 2020
Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in GermanyMelissa Schmidt, Donna P Ankerst, Yiyao Chen, et al.
Breast Cancer Research and Treatment|September 27, 2021
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1Leonie Neirich, Maryam Yahiaoui-Doktor, Jacqueline Lammert, et al.
Journal of Medical Genetics|October 24, 2006
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutationsMartin Zenker, Katarina Lehmann, Anna Leana Schulz, et al.
Pageof 3